Literature DB >> 26714415

Tumor Associated Mesenchymal Stromal Cells Show Higher Immunosuppressive and Angiogenic Properties Compared to Adipose Derived MSCs.

Ladan Langroudi1, Zuhair Muhammad Hassan, Masoud Soleimani, Seyed Mahmoud Hashemi.   

Abstract

BACKGROUND: Differentiation, migratory properties and availability of Mesenchymal Stromal Cells (MSC) have become an important part of biomedical research. However, the functional heterogeneity of cells derived from different tissues has hampered providing definitive phenotypic markers for these cells.
OBJECTIVE: To characterize and compare the phenotype and cytokines of adipose derived MSCs (AD-MSCs) and tumoral-MSCs (T-MSCs) isolated from mammary tumors of BALB/c mice.
METHODS: Immunophenotyping and in vitro differentiation tests were used for MSC characterization. Cytokine and enzyme profiles were assessed using ELISA and Real-time PCR, respectively.
RESULTS: T-MSCs expressed significantly higher levels of HLA-DR (p=0.04). Higher levels of PGE2 and COX-2 enzyme were also observed in T-MSCs (p=0.07 and p=0.00, respectively). Additionally, T-MSCs expressed higher levels of iNOS and MMP9 (p=0.01 and p=0.01, respectively). T-MSCs were also able to induce higher levels of proliferation and migration of HUVEC endothelial cells in wound scratch assay compared to AD-MSCs (p=0.015).
CONCLUSION: Functional differences showed by the surface markers of MSCs, cytokine and enzyme production indicate the effect of different microenvironments on MSCs phenotype and function.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26714415     DOI: IJIv12i4A1

Source DB:  PubMed          Journal:  Iran J Immunol        ISSN: 1735-1383            Impact factor:   1.603


  5 in total

1.  hUC-MSCs: evaluation of acute and long-term routine toxicity testing in mice and rats.

Authors:  Jianwei Xu; Gang Liu; Xianyao Wang; Ya'nan Hu; Hongyang Luo; Lan Ye; Zhanhui Feng; Chen Li; Menglan Kuang; Lijuan Zhang; Yixia Zhou; Xiaolan Qi
Journal:  Cytotechnology       Date:  2022-01-05       Impact factor: 2.058

2.  Role of microRNA 146a on the healing of cornea alkali burn treated with mesenchymal stem cells.

Authors:  Xu Luo; Jianmin Li; Lihui Yin; Jian Pan; Yang Zhang; Zipei Jiang
Journal:  Mol Med Rep       Date:  2018-07-27       Impact factor: 2.952

3.  The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells.

Authors:  Daniel Ryan; Bibbin T Paul; Jim Koziol; Wael M ElShamy
Journal:  Breast Cancer Res       Date:  2019-04-24       Impact factor: 6.466

Review 4.  Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies.

Authors:  Noha Attia; Mohamed Mashal; Sudhakar Pemminati; Adekunle Omole; Carolyn Edmondson; Will Jones; Priyanka Priyadarshini; Temoria Mughal; Pauline Aziz; Blesing Zenick; Ambar Perez; Morgan Lacken
Journal:  Cells       Date:  2021-12-30       Impact factor: 6.600

Review 5.  Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.

Authors:  Qing Zhang; Wei Xiang; Dong-Ye Yi; Bing-Zhou Xue; Wan-Wan Wen; Ahmed Abdelmaksoud; Nan-Xiang Xiong; Xiao-Bing Jiang; Hong-Yang Zhao; Peng Fu
Journal:  Stem Cell Res Ther       Date:  2018-08-24       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.